Home › NCT06709404

Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers

Telehealth Intervention to Address Distress and Financial Toxicity in the Care Partners of Patients Receiving Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Who can join

Ages 18 and older · All sexes

Inclusion Criteria

* Primary caregiver of a patient scheduled to receive CS+HIPEC at Atrium Health Wake Forest Baptist Comprehensive Cancer Center
* Access to a computer or smartphone and must have an email address
* 18 years of age or older at the time of consent
* The ability to understand and willingness to provide written informed consent
* The ability to read and write English

Exclusion Criteria

\- Patient declines access to their medical record

About the study

This clinical trial assesses whether resource identification for primary caregivers can affect financial stress, quality of life, depression, and the general belief in the ability to cope with daily life. Caregivers of patients receiving cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS+HIPEC) demonstrate that they endure high depressive symptom burdens and financial distress. Further, they experience symptom trajectories that differ from those of patients. In short, they require differential timing of supportive interventions. This study aims to reduce financial toxicity and distress levels and to increase self-efficacy, satisfaction and engagement with care. Information gathered from this study may help researchers determine whether telehealth interventions for caregivers may increase awareness of recommended resources that could be beneficial during caregivers journey.

What is being tested

• Telemedicine (other)
• Survey administration (other)
• Electronic health record review (other)
• Best Practice (other)

Sponsor: Wake Forest University Health Sciences · Participants: 50 · Started: Jan 31, 2025

Contact the study team

• Study Coordinator · Phone: 3367165772

Official record on ClinicalTrials.gov — NCT06709404

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.